A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...
Carnegie Mellon received $28.5 million to develop liver tissue bioprinting, with hopes it can reduce the need for transplants ...
Dr. Tristan Jediah Labitad, head of the DOH-10 Non-Communicable Diseases Cluster, discusses the role of the liver during the ...
New report highlights progress and persistent gaps in global viral hepatitis elimination, underscoring need to expand testing ...
Liver fibrosis has shown potential to be reversed.Liver fibrosis is a condition where scar tissue builds up in the liver due ...
A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback